The project, which is an initiative of the Quest Diagnostics Foundation, aims to expand healthcare access in the area, including through no-cost laboratory testing.
The guidelines address items like interpretation of results that may be affected by gender-affirming hormone therapy and improving electronic health record practices.
Last week, readers were most interested in a story about Achieve Diagnostics buying the pharmacogenomic assets of H&M Molecular Diagnostics.
The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.
The firm currently offers its HerResolve multiomic test for endometriosis that looks at seven biomarkers, including microRNAs ...
The planned trial will investigate Eledon's tegoprubart, a therapy designed to prevent organ rejection in kidney transplantation.
The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.
Verici Dx said on Wednesday that its Tutivia lab-developed test for acute kidney transplant rejection risk has been approved by the New York State Department of Health (NYSDOH). With the approval ...
The Germany-based company is developing a handheld infectious disease testing platform that does not require electricity.
NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results